All In Biotech

Drug Trial Radar · NCT03094416

Levothyroxine Sodium in Thyroidectomized Patients Taking Proton Pump Inhibitors

An Open-label Therapeutic Efficacy Study of Tirosint (Levothyroxine Sodium) Capsules in Thyroidectomized Patients Taking Proton Pump Inhibitors

Last checked: Nov 20, 2026Latest source record: Apr 5, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

66

Actual

Start

Jul 30, 2018

Primary completion

Jun 15, 2020

Study completion Jun 15, 2020

Sponsor

Lead sponsor
IBSA Institut Biochimique SAIndustry
Sponsor type
Industry
First posted
Mar 29, 2017

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is an open-label therapeutic efficacy study of Tirosint (levothyroxine sodium) capsules in thyroidectomized patients taking proton pump inhibitors and levothyroxine, evaluating changes in serum levels of Thyroid Stimulating Hormone (TSH) upon switch to Tirosint with respect to baseline.

Conditions

  • Hypothyroidism;Postablative

Interventions

  • levothyroxine sodium capsuleDrug

    after the run-in period, patients will be switched to levothyroxine sodium capsule at the same dose used during run-in

  • Proton pump inhibitor (PPI)Drug

    for the whole study duration all subjects will keep taking their proton pump inhibitor medication, as per prescription and as before inclusion

  • Levothyroxine Sodium (LT4) TabletsDrug

    during the run-in period, subjects will continue taking their levothyroxine sodium tablet medication as per prescription and as before inclusion

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Thyroid Stimulating Hormone (TSH)Time frame: baseline and 12 weeks

Locations

9 sites in 1 country. Site status is shown where the registry gives one.

  • California Head and Neck Specialists

    La Jolla, California

  • Coastal Metabolic Research Centre

    Ventura, California

  • Washington Hospital Center

    Washington D.C., District of Columbia

  • MedStar Union Memorial Hospital

    Baltimore, Maryland

  • NYC Health + Hospitals/ Queens

    New York, New York

  • Diabetes & Endocrinology Consultants, PC

    Morehead City, North Carolina

  • Carolina Ear Nose and Throat Clinic

    Orangeburg, South Carolina

  • Virginia Commonwealth University

    Richmond, Virginia

  • Stonesifer Endocrine Care & Clinical Research Inc., PS

    Federal Way, Washington

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.